These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29158552)

  • 1. Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray.
    Hayeems RZ; Bhawra J; Tsiplova K; Meyn MS; Monfared N; Bowdin S; Stavropoulos DJ; Marshall CR; Basran R; Shuman C; Ito S; Cohn I; Hum C; Girdea M; Brudno M; Cohn RD; Scherer SW; Ungar WJ
    Eur J Hum Genet; 2017 Dec; 25(12):1303-1312. PubMed ID: 29158552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of Genome and Exome Sequencing in Children Diagnosed with Autism Spectrum Disorder.
    Yuen T; Carter MT; Szatmari P; Ungar WJ
    Appl Health Econ Health Policy; 2018 Aug; 16(4):481-493. PubMed ID: 29651777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of whole genome sequencing in neurodevelopmental disorders.
    Runheim H; Pettersson M; Hammarsjö A; Nordgren A; Henriksson M; Lindstrand A; Levin LÅ; Soller MJ
    Sci Rep; 2023 Apr; 13(1):6904. PubMed ID: 37106068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micro-costing diagnostics in oncology: from single-gene testing to whole- genome sequencing.
    Pasmans CTB; Tops BBJ; Steeghs EMP; Coupé VMH; Grünberg K; de Jong EK; Schuuring EMD; Willems SM; Ligtenberg MJL; Retèl VP; van Snellenberg H; de Bruijn E; Cuppen E; Frederix GWJ
    Expert Rev Pharmacoecon Outcomes Res; 2021 Jun; 21(3):413-414. PubMed ID: 33852815
    [No Abstract]   [Full Text] [Related]  

  • 5. A microcosting and cost-consequence analysis of clinical genomic testing strategies in autism spectrum disorder.
    Tsiplova K; Zur RM; Marshall CR; Stavropoulos DJ; Pereira SL; Merico D; Young EJ; Sung WWL; Scherer SW; Ungar WJ
    Genet Med; 2017 Nov; 19(11):1268-1275. PubMed ID: 28471434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From cytogenetics to cytogenomics: whole-genome sequencing as a first-line test comprehensively captures the diverse spectrum of disease-causing genetic variation underlying intellectual disability.
    Lindstrand A; Eisfeldt J; Pettersson M; Carvalho CMB; Kvarnung M; Grigelioniene G; Anderlid BM; Bjerin O; Gustavsson P; Hammarsjö A; Georgii-Hemming P; Iwarsson E; Johansson-Soller M; Lagerstedt-Robinson K; Lieden A; Magnusson M; Martin M; Malmgren H; Nordenskjöld M; Norling A; Sahlin E; Stranneheim H; Tham E; Wincent J; Ygberg S; Wedell A; Wirta V; Nordgren A; Lundin J; Nilsson D
    Genome Med; 2019 Nov; 11(1):68. PubMed ID: 31694722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole Genome Sequencing in the Evaluation of Fetal Structural Anomalies: A Parallel Test with Chromosomal Microarray Plus Whole Exome Sequencing.
    Zhou J; Yang Z; Sun J; Liu L; Zhou X; Liu F; Xing Y; Cui S; Xiong S; Liu X; Yang Y; Wei X; Zou G; Wang Z; Wei X; Wang Y; Zhang Y; Yan S; Wu F; Zeng F; Wang J; Duan T; Peng Z; Sun L
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33800913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term costs of integrating whole-genome sequencing into primary care and cardiology settings: a pilot randomized trial.
    Christensen KD; Vassy JL; Phillips KA; Blout CL; Azzariti DR; Lu CY; Robinson JO; Lee K; Douglas MP; Yeh JM; Machini K; Stout NK; Rehm HL; McGuire AL; Green RC; Dukhovny D;
    Genet Med; 2018 Dec; 20(12):1544-1553. PubMed ID: 29565423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental net benefit of whole genome sequencing for newborns and children with suspected genetic disorders: Systematic review and meta-analysis of cost-effectiveness evidence.
    Nurchis MC; Riccardi MT; Radio FC; Chillemi G; Bertini ES; Tartaglia M; Cicchetti A; Dallapiccola B; Damiani G
    Health Policy; 2022 Apr; 126(4):337-345. PubMed ID: 35317923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole Genome Sequencing Expands Diagnostic Utility and Improves Clinical Management in Pediatric Medicine.
    Stavropoulos DJ; Merico D; Jobling R; Bowdin S; Monfared N; Thiruvahindrapuram B; Nalpathamkalam T; Pellecchia G; Yuen RKC; Szego MJ; Hayeems RZ; Shaul RZ; Brudno M; Girdea M; Frey B; Alipanahi B; Ahmed S; Babul-Hirji R; Porras RB; Carter MT; Chad L; Chaudhry A; Chitayat D; Doust SJ; Cytrynbaum C; Dupuis L; Ejaz R; Fishman L; Guerin A; Hashemi B; Helal M; Hewson S; Inbar-Feigenberg M; Kannu P; Karp N; Kim R; Kronick J; Liston E; MacDonald H; Mercimek-Mahmutoglu S; Mendoza-Londono R; Nasr E; Nimmo G; Parkinson N; Quercia N; Raiman J; Roifman M; Schulze A; Shugar A; Shuman C; Sinajon P; Siriwardena K; Weksberg R; Yoon G; Carew C; Erickson R; Leach RA; Klein R; Ray PN; Meyn MS; Scherer SW; Cohn RD; Marshall CR
    NPJ Genom Med; 2016 Jan; 1():15012-. PubMed ID: 28567303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases.
    Clark MM; Stark Z; Farnaes L; Tan TY; White SM; Dimmock D; Kingsmore SF
    NPJ Genom Med; 2018; 3():16. PubMed ID: 30002876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capturing the clinical utility of genomic testing: medical recommendations following pediatric microarray.
    Hayeems RZ; Hoang N; Chenier S; Stavropoulos DJ; Pu S; Weksberg R; Shuman C
    Eur J Hum Genet; 2015 Sep; 23(9):1135-41. PubMed ID: 25491637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey of undetected, clinically relevant chromosome abnormalities when replacing postnatal karyotyping by Whole Genome Sequencing.
    Hochstenbach R; van Binsbergen E; Schuring-Blom H; Buijs A; Ploos van Amstel HK
    Eur J Med Genet; 2019 Sep; 62(9):103543. PubMed ID: 30248410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exome Sequencing for Prenatal Detection of Genetic Abnormalities in Fetal Ultrasound Anomalies: An Economic Evaluation.
    Kodabuckus SS; Quinlan-Jones E; McMullan DJ; Maher ER; Hurles ME; Barton PM; Kilby MD
    Fetal Diagn Ther; 2020; 47(7):554-564. PubMed ID: 31962312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comparison of Whole Genome Sequencing to Multigene Panel Testing in Hypertrophic Cardiomyopathy Patients.
    Cirino AL; Lakdawala NK; McDonough B; Conner L; Adler D; Weinfeld M; O'Gara P; Rehm HL; Machini K; Lebo M; Blout C; Green RC; MacRae CA; Seidman CE; Ho CY;
    Circ Cardiovasc Genet; 2017 Oct; 10(5):. PubMed ID: 29030401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive prenatal diagnostics: Exome versus genome sequencing.
    Miceikaite I; Fagerberg C; Brasch-Andersen C; Torring PM; Kristiansen BS; Hao Q; Sperling L; Ibsen MH; Löser K; Bendsen EA; Ousager LB; Larsen MJ
    Prenat Diagn; 2023 Aug; 43(9):1132-1141. PubMed ID: 37355983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test.
    Lionel AC; Costain G; Monfared N; Walker S; Reuter MS; Hosseini SM; Thiruvahindrapuram B; Merico D; Jobling R; Nalpathamkalam T; Pellecchia G; Sung WWL; Wang Z; Bikangaga P; Boelman C; Carter MT; Cordeiro D; Cytrynbaum C; Dell SD; Dhir P; Dowling JJ; Heon E; Hewson S; Hiraki L; Inbar-Feigenberg M; Klatt R; Kronick J; Laxer RM; Licht C; MacDonald H; Mercimek-Andrews S; Mendoza-Londono R; Piscione T; Schneider R; Schulze A; Silverman E; Siriwardena K; Snead OC; Sondheimer N; Sutherland J; Vincent A; Wasserman JD; Weksberg R; Shuman C; Carew C; Szego MJ; Hayeems RZ; Basran R; Stavropoulos DJ; Ray PN; Bowdin S; Meyn MS; Cohn RD; Scherer SW; Marshall CR
    Genet Med; 2018 Apr; 20(4):435-443. PubMed ID: 28771251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copy-Number Variants Detection by Low-Pass Whole-Genome Sequencing.
    Dong Z; Xie W; Chen H; Xu J; Wang H; Li Y; Wang J; Chen F; Choy KW; Jiang H
    Curr Protoc Hum Genet; 2017 Jul; 94():8.17.1-8.17.16. PubMed ID: 28696555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periodic reanalysis of whole-genome sequencing data enhances the diagnostic advantage over standard clinical genetic testing.
    Costain G; Jobling R; Walker S; Reuter MS; Snell M; Bowdin S; Cohn RD; Dupuis L; Hewson S; Mercimek-Andrews S; Shuman C; Sondheimer N; Weksberg R; Yoon G; Meyn MS; Stavropoulos DJ; Scherer SW; Mendoza-Londono R; Marshall CR
    Eur J Hum Genet; 2018 May; 26(5):740-744. PubMed ID: 29453418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-Pass Genome Sequencing: Validation and Diagnostic Utility from 409 Clinical Cases of Low-Pass Genome Sequencing for the Detection of Copy Number Variants to Replace Constitutional Microarray.
    Chaubey A; Shenoy S; Mathur A; Ma Z; Valencia CA; Reddy Nallamilli BR; Szekeres E; Stansberry L; Liu R; Hegde MR
    J Mol Diagn; 2020 Jun; 22(6):823-840. PubMed ID: 32344035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.